
China Pharma
(NYSEMKT) CPHI
China Pharma Financials at a Glance
Market Cap
$3.06M
Revenue (TTM)
$4.05M
Net Income (TTM)
$3.19M
EPS (TTM)
$-1.03
P/E Ratio
-0.59
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$0.63
Volume
100
Open
$0.63
Price
$0.63
Volume
100
Open
$0.63
Previous Close
$0.63
Daily Range
$0.63 - $0.63
52-Week Range
$0.50 - $2.65
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$0.63
Volume
100
Open
$0.63
Previous Close
$0.63
Daily Range
$0.63 - $0.63
52-Week Range
$0.50 - $2.65
CPHI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout China Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
231
CEO
Zhi Lin Li
Website
www.chinapharmaholdings.comHeadquarters
Haikou, 570216, CN
CPHI Financials
Key Financial Metrics (TTM)
Gross Margin
-8%
Operating Margin
-80%
Net Income Margin
-79%
Return on Equity
-42%
Return on Capital
-35%
Return on Assets
-20%
Earnings Yield
-1.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.06M
Shares Outstanding
5.02M
Volume
100
Short Interest
0.00%
Avg. Volume
50.10K
Financials (TTM)
Gross Profit
$1.99M
Operating Income
$4.59M
EBITDA
$1.96M
Operating Cash Flow
$466.36K
Capital Expenditure
$291.72K
Free Cash Flow
$758.08K
Cash & ST Invst.
$626.88K
Total Debt
$3.59M
China Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$756.22K
-31.3%
Gross Profit
$59.65K
+88.5%
Gross Margin
-7.89%
N/A
Market Cap
$3.06M
N/A
Market Cap/Employee
$13.68K
N/A
Employees
224
N/A
Net Income
$651.48K
+41.7%
EBITDA
$271.40K
+29.8%
Quarterly Fundamentals
Net Cash
$3.27M
+0.6%
Accounts Receivable
$285.91K
-29.7%
Inventory
$1.67M
-33.0%
Long Term Debt
$128.26K
-91.0%
Short Term Debt
$3.44M
+33.1%
Return on Assets
-19.96%
N/A
Return on Invested Capital
-34.55%
N/A
Free Cash Flow
$237.60K
-529.7%
Operating Cash Flow
$236.99K
-404.7%